Work

Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial

Year: 2009

Type: article

Study design: Observational Study

Source: ADHD Attention Deficit and Hyperactivity Disorders

DOI: 10.1007/s12402-009-0010-6

Authors: Martin Gerwe, Kirsten Stollhoff, Jacek Mossakowski, Hans-Juergen Kuehle, Ulrich Goertz, Christopher Schaefer, Manuela Bogdanow, Steffen Heger

Institutions: Johnson & Johnson (Germany), Janssen (Germany), ClinAssess (Germany)

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2063445955

FWCI:

Cites: 44

Cited by: 7

Related to: 10